Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults

This paper presents mechanism of action and antimicrobial spectrum of macrolides as well as the known acquired resistance mechanisms in the common pathogens causing community-acquired pneumonia, such as Streptococcus pneumoniae and Mycoplasma pneumoniae. Non-antimicrobial (anti-inflammatory and immu...

Full description

Bibliographic Details
Main Authors: Sinopalnikov A.I., Rachina S.A., Zakharenkov I.A.
Format: Article
Language:Russian
Published: Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2019-12-01
Series:Клиническая микробиология и антимикробная химиотерапия
Subjects:
Online Access:https://cmac-journal.ru/publication/2019/3/cmac-2019-t21-n3-p217/cmac-2019-t21-n3-p217.pdf
id doaj-9269860b49aa4eeb80478b6266cfaf60
record_format Article
spelling doaj-9269860b49aa4eeb80478b6266cfaf602020-11-25T00:57:41ZrusInterregional Association for Clinical Microbiology and Antimicrobial ChemotherapyКлиническая микробиология и антимикробная химиотерапия1684-43862686-95862019-12-0121321722310.36488/cmac.2019.3.217-223cmac-2019-t21-n3-p217Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adultsSinopalnikov A.I.0Rachina S.A.1Zakharenkov I.A.2Russian Medical Academy of Continuous Professional Education, Moscow, RussiaRUDN University, Moscow, RussiaBryansk City HospitalThis paper presents mechanism of action and antimicrobial spectrum of macrolides as well as the known acquired resistance mechanisms in the common pathogens causing community-acquired pneumonia, such as Streptococcus pneumoniae and Mycoplasma pneumoniae. Non-antimicrobial (anti-inflammatory and immunomodulatory) effects of macrolides that have been found in experimental and clinical studies are described in detail. Results of clinical studies and current practice guidelines which determine potential benefits and a role of macrolides in the antibacterial therapy of severe community-acquired pneumonia in adults are reviewed.https://cmac-journal.ru/publication/2019/3/cmac-2019-t21-n3-p217/cmac-2019-t21-n3-p217.pdfcommunity-acquired pneumoniaantibacterial therapymacrolidesimmunomodulatory effects
collection DOAJ
language Russian
format Article
sources DOAJ
author Sinopalnikov A.I.
Rachina S.A.
Zakharenkov I.A.
spellingShingle Sinopalnikov A.I.
Rachina S.A.
Zakharenkov I.A.
Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
Клиническая микробиология и антимикробная химиотерапия
community-acquired pneumonia
antibacterial therapy
macrolides
immunomodulatory effects
author_facet Sinopalnikov A.I.
Rachina S.A.
Zakharenkov I.A.
author_sort Sinopalnikov A.I.
title Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
title_short Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
title_full Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
title_fullStr Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
title_full_unstemmed Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
title_sort potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
publisher Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
series Клиническая микробиология и антимикробная химиотерапия
issn 1684-4386
2686-9586
publishDate 2019-12-01
description This paper presents mechanism of action and antimicrobial spectrum of macrolides as well as the known acquired resistance mechanisms in the common pathogens causing community-acquired pneumonia, such as Streptococcus pneumoniae and Mycoplasma pneumoniae. Non-antimicrobial (anti-inflammatory and immunomodulatory) effects of macrolides that have been found in experimental and clinical studies are described in detail. Results of clinical studies and current practice guidelines which determine potential benefits and a role of macrolides in the antibacterial therapy of severe community-acquired pneumonia in adults are reviewed.
topic community-acquired pneumonia
antibacterial therapy
macrolides
immunomodulatory effects
url https://cmac-journal.ru/publication/2019/3/cmac-2019-t21-n3-p217/cmac-2019-t21-n3-p217.pdf
work_keys_str_mv AT sinopalnikovai potentialfortheuseofmacrolidesintheantimicrobialtherapyofseverecommunityacquiredpneumoniainadults
AT rachinasa potentialfortheuseofmacrolidesintheantimicrobialtherapyofseverecommunityacquiredpneumoniainadults
AT zakharenkovia potentialfortheuseofmacrolidesintheantimicrobialtherapyofseverecommunityacquiredpneumoniainadults
_version_ 1725222772215382016